The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mor, F.
Right arrow Articles by Cohen, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mor, F.
Right arrow Articles by Cohen, I. R.
The Journal of Immunology, 2003, 170: 628-634.
Copyright © 2003 by The American Association of Immunologists

Autoimmune Encephalomyelitis and Uveitis Induced by T Cell Immunity to Self {beta}-Synuclein1

Felix Mor2, Francisco Quintana, Avishai Mimran and Irun R. Cohen

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel

{beta}-synuclein is a neuronal protein that accumulates in the plaques that characterize neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases. It has been proposed that immunization to peptides of plaque-forming proteins might be used therapeutically to help dissociate pathogenic plaques in the brain. We now report that immunization of Lewis rats with a peptide from {beta}-synuclein resulted in acute paralytic encephalomyelitis and uveitis. T cell lines and clones reactive to the peptide adoptively transferred the disease to naive rats. Immunoblotting revealed the presence of {beta}-synuclein in heavy myelin, indicating that the expression of {beta}-synuclein is not confined to neurons. These results add {beta}-synuclein to the roster of encephalitogenic self Ags, point out the potential danger of therapeutic autoimmunization to {beta}-synuclein, and alert us to the unsuspected possibility that autoimmunity to {beta}-synuclein might play an inflammatory role in the pathogenesis of neurodegeneration.


Related articles in The JI:

In This Issue

The JI 2003 170: 3-4. [Full Text]  



This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Winkler-Pickett, H. A. Young, J. M. Cherry, J. Diehl, J. Wine, T. Back, W. E. Bere, A. T. Mason, and J. R. Ortaldo
In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses
J. Immunol., April 1, 2008; 180(7): 4495 - 4506.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Mor, M. Izak, and I. R. Cohen
Identification of Aldolase as a Target Antigen in Alzheimer's Disease
J. Immunol., September 1, 2005; 175(5): 3439 - 3445.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Mor, F. J. Quintana, and I. R. Cohen
Angiogenesis-Inflammation Cross-Talk: Vascular Endothelial Growth Factor Is Secreted by Activated T Cells and Induces Th1 Polarization
J. Immunol., April 1, 2004; 172(7): 4618 - 4623.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.